Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter) or Amirah Al Idrus (email | Twitter), and we will feature it here at the end of each week.
Sanofi's CEO search leads to Brandicourt |
||||||||||||||||||||
Throughout the week, rumors, and then reports, began to surface about Sanofi's ($SNY) new CEO, Olivier Brandicourt. The French drugmaker confirmed the speculation on Thursday with a brief news release announcing that it had snagged Brandicourt from the top pharma spot at Bayer Healthcare; the new helmsman will begin his Sanofi position on April 2. With a 28-year background and having worked in leadership positions at Bayer and Pfizer ($PFE), Sanofi Chairman Serge Weinberg said Brandicourt's "strong experience combined with his international profile, deep knowledge of U.S. and emerging healthcare markets, and his capability to unite teams will provide new dynamism to Sanofi's strategy of diversification and innovation." Brandicourt is a medical doctor and was educated in Paris, which one analyst called the "icing on the cake" for Sanofi. Brandicourt will replace Chris Viehbacher, who was ousted in October by the company's board. Story | Release
|